Clinical Trial Safety Intern - Working in Science 2026 Internship Program at AstraZeneca
Warsaw, Masovian Voivodeship, Poland -
Full Time


Start Date

Immediate

Expiry Date

31 May, 26

Salary

0.0

Posted On

02 Mar, 26

Experience

0 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

No

Skills

Attention-to-detail, Analytical Skills, Time Management, ICH/GCP Guidelines Knowledge, SAE Reporting Requirements Knowledge, Summarization

Industry

Pharmaceutical Manufacturing

Description
Clinical Trial Safety Intern ​- Working in Science 2026 Internship Program Turn your curiosity into impact. Join AstraZeneca for a 3 – month hybrid internship starting in July and work with teams pushing the boundaries of science. About the program The Working in Science Internship Program is designed for last year's students and recent graduates who want to apply what they’ve learned in a real, global biotechnology environment. You’ll contribute to meaningful projects, gain mentorship, and develop skills that set you up for future success. Department description: TRIal SAfety Review Centre (TRISARC) ​is the team responsible for conducting first line review of critical data from a medical perspective to ensure medical completeness and accuracy of collected data.​ TRISARC ensures readiness of medically consistent critical data for regulatory authorities to register new medicines ​for our patients faster. ​ We act as a bridge between science and operations/technical areas. We enable standardization and efficiency while working with a large amount of clinical data.​ General hiring requirements Required skills, candidate background: Educational degree (BSc/Msc/PhD) in Life Science or equivalent work experience in directly related fields (preferably medicine, pharmacy, veterinary, biotechnology, nurse, dentist) Knowledge of ICH/GCP Guidelines Knowledge of SAE reporting requirements Strong attention-to-detail, analytical skills, and ability to concisely summarize large amounts of complex information Ability to multi-task in a high-volume environment with shifting priorities Excellent time management Key details Eligibility: Final year students and recent graduates. Please review the specific requirements for each role. Duration: 3 months, starting in July. Working model: Hybrid, with partial on‑site presence. Selection process: Application review against objective criteria, HireVue video responses, then a remote meeting with the recruiting team. Timeline: Apply by 21 March 2026. Results by mid-April. Important information Completion of the internship does not guarantee contract extension or further employment at AstraZeneca. Future opportunities may be advertised separately and require a new application. How to apply Read the role description carefully and submit your application before the deadline. Shortlisted candidates will receive an invitation to complete HireVue. You can also connect with our community and learn more about the program via our LinkedIn group: https://qr.short.az/Join_our_LinkedInGroup Date Posted 01-mar-2026 Closing Date 21-mar-2026 AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
Responsibilities
The intern will contribute to meaningful projects within the TRIal SAfety Review Centre (TRISARC), which is responsible for the first-line review of critical medical data to ensure completeness and accuracy for regulatory submissions. This role acts as a bridge between science and operations, enabling standardization while working with large volumes of clinical data.
Loading...